Basics IGM Biosciences, Inc. IPO Date: September 16, 2019 Sector: Healthcare Industry: Biotech Market Cap: $76.57M Activated in VL: False Average Daily Range Avg Daily Range: $1.32 | 4.31% Avg Daily Range (30 D): $0.01 | 0.84% Avg Daily Range (90 D): $0.03 | 2.21% Institutional Daily Volume Avg Daily Volume: .26M Avg Daily Volume (30 D): .23M Avg Daily Volume (90 D): .4M Trade Size Avg Trade Size (Sh.): 77 Avg Trade Size (Sh.) (30 D): 587 Avg Trade Size (Sh.) (90 D): 340 Institutional Trades Total Inst.Trades: 723 Avg Inst. Trade: $1.57M Avg Inst. Trade (30 D): $1.22M Avg Inst. Trade (90 D): $1.07M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.86M Avg Closing Trade (30 D): $1.22M Avg Closing Trade (90 D): $1.35M Avg Closing Volume: 56.47K     News Jul 5, 2025 @ 1:38 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Halper Sadeh Llc Jan 9, 2025 @ 6:00 PM IGM Biosciences Provides Strategic Update on Autoi... Source: N/A Nov 4, 2024 @ 12:00 PM IGM Biosciences to Present at Three Upcoming Inves... Source: N/A Sep 18, 2024 @ 3:22 PM Russell 2000 Outpaces S&P 500 As Small Caps Antici... Source: Surbhi Jain Jul 12, 2024 @ 8:25 PM Russell 2000 Index Notches Strongest Week Of Year,... Source: Piero Cingari, Benzinga Staff Writer Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.89 $1.59 $-.86 Diluted EPS $-.9 $1.58 $-.86 Revenue $ 145.05M $ 143.62M $ .5M Gross Profit $ $ $ Net Income / Loss $ -53.39M $ 97.58M $ -52.89M Operating Income / Loss $ -61.88M $ 96.26M $ -54.78M Cost of Revenue $ $ $ Net Cash Flow $ -36.61M $ -6.24M $ 10.22M PE Ratio